πŸ‡ΊπŸ‡Έ FDA
Patent

US 8449890

Neprilysin inhibitors

granted A61KA61K31/415A61K31/4192

Quick answer

US patent 8449890 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/415, A61K31/4192, A61K31/4196, A61K31/42